The Adipocyte, Fatty Acid Trapping, and Atherogenesis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
uch effort has been spent to identify the factors that contribute to coronary artery disease.Not surprisingly, adipose tissue has gained little attention to date in this search because no immediate and critical links between adipocyte metabolism and atherogenesis may be evident to most people.But coronary artery disease is a public health problem only in societies with high fatty acid intakes; therefore, our purpose is to outline a hypothesis that adipose tissue dysfunction may be a very common-indeed, perhaps even the most commoncause of the dyslipoproteinemia and insulin resistance that so frequently lead to coronary disease.This complex and multifaceted syndrome has received many names, depending on the original point of interest.Amongst these names are hyper-apoB, 1 familial combined hyperlipidemia, 2 syndrome X, 3 the plurimetabolic syndrome, 4 the visceral fat syndrome, 5 familial dyslipidemic hypertension, 6 the atherogenic lipoprotein phenotype, 7 and the deadly quartet.8 Whether these titles are different names for the same disorder or different disorders with similar features is not clear; but it is the pathophysiology of their common features on which we will concentrate.Among the most important of these features are increased numbers of the smaller, denser LDL particles, postprandial hyperlipemia, hypertriglyceridemia, low HDL cholesterol, high fasting and postprandial fatty acid levels, and insulin resistance.Until now, excess release of fatty acids from adipocytes caused by increased lipolysis 9 has been the only mechanism suggested to link adipocyte dysfunction and dyslipidemia.In our opinion, although excess lipolysis may be of importance in certain situations, it is not likely to be the sole link between adipose tissue dysfunction and atherosclerosis.The hypothesis that will be outlined herein differs substantially from the current views and is based on the metabolic insights that have been gained from the recent recognition of the ASP pathway.10 Along with insulin, ASP is a principal determinant of the rate of triglyceride synthesis in adipocytes 11 and therefore is a principal determinant of the rate of fatty acid uptake or, as we shall describe it herein, fatty acid trapping by adipocytes.In brief, we postulate that failure to trap the normal proportion of dietary fatty acids in adipocytes leads to their abnormal diversion to liver and muscle, and from this abnormal diversion stems the complex array of metabolic alterations listed above that so markedly increase the risk of vascular disease in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“Fatty acids compete with glucose for entry and oxidation by muscle.(36) They also impede insulin extraction by the liver(37) and stimulate hepatic gluconeogenesis.”
BackgroundAtherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050 · cited 1×
“They also impede insulin extraction by the liver(37) and stimulate hepatic gluconeogenesis.(38) Given the in vitro data that indicate ASP affects glucose transport in skeletal muscle,(15) reduced responsiveness to ASP would be expected to reduce both fatty acid and glucose extraction by this tissue.”
BackgroundFrayn, K. N., Shadid, S., Hamlani, R., Humphreys, S. M., Clark, M. L., Fielding, B. A., Boland, O., & Coppack, S. W. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.3.e308 · Cited by 188 · cited 1×
“acids released from chylomicrons are trapped immediately by adipocytes, and half enter the general circulation.(26) If fatty acid”
BackgroundSelf-citation
Cited by
Adipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752
“Thus, the pathway of fatty acid uptake, or ‘fatty acid trapping’ [30], plays an important part in regulating NEFA delivery from adipose tissue in the postprandial state.”
BackgroundSelf-citationBurdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598
“Plasma NEFA concentration represents the net contributions of the release of fatty acids from adipose tissue by the action of hormone-sensitive lipase, incomplete entrapment of fatty acids released from lipoproteins by lipoprotein lipase activity and uptake into tissues (Sniderman et al. 1998).”
BackgroundCritical review of acylation-stimulating protein physiology in humans and rodents
Cianflone, K., Xia, Z., & Chen, L. Y. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00686-7 · Cited by 364
Self-citationPostprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Sniderman, A. D., Bhopal, R., Prabhakaran, D., Sarrafzadegan, N., & Tchernof, A. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dyl245 · Cited by 343
Self-citationSniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Self-citationDusserre, E., Moulin, P., & Vidal, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00091-5 · Cited by 323
Adipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men
Abate, N., Chandalia, M., Snell, P. G., & Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031843 · Cited by 201
“Adipose tissue is the only major tissue in which triacylglycerol clearance from lipoproteins and fatty acid trapping are specifically up-regulated during hyperinsulinemia (30, 31).”
Wolever, T. M., & Mehling, C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.612 · Cited by 190
van Oostrom, A. J. H. H. M., Alipour, A., Plokker, T. W. M., Sniderman, A. D., & Cabezas, M. C. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.009 · Cited by 102
Self-citationIn vivo regulation of plasma free fatty acids in insulin resistance
Mook, S., Halkes, C. J. M., Bilecen, S., & Cabezas, M. C. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.023 · Cited by 59
Meijssen, S., van Dijk, H., Verseyden, C., Erkelens, D. W., & Cabezas, M. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000014079.98335.72 · Cited by 57
van Oostrom, A. J., van Dijk, H., Verseyden, C., Sniderman, A. D., Cianflone, K., Rabelink, T. J., & Castro Cabezas, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.510 · Cited by 53
“The C3-ASP system is a potentially important mediator of peripheral FFA handling and is of particular importance in the postprandial state because chylomicrons are produced in the postprandial state and are the strongest activators of this system (9, 10, 15).”
BackgroundSelf-citationMeijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Halkes, C. J. M., van Dijk, H., Verseyden, C., de Jaegere, P. P. T., Plokker, H. W. M., Meijssen, S., Erkelens, D. W., & Cabezas, M. C. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000092326.00725.ed · Cited by 43
Metadata
- Authors
- Sniderman, A. D., Cianflone, K., Arner, P., Summers, L. K. M., & Frayn, K. N.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1998-02
- Volume
- 18
- Issue
- 2
- Pages
- 147-151
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2055197573
- Cited by
- 123
- References
- 4
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.